Hindustan Unilever Ltd

Meeting Details

• Date: 17 August 2026; mode: physical; type: conference.
• Organizer: Motilal Oswal 22nd Annual Global Investor Conference.

Participants

• Key participants: Management Representatives from Hindustan Unilever Limited.

Purpose

• Purpose: participate in investor meet for dialogue with investors.

Meeting Details

• Earnings Conference Call recording for quarter ended 30 June 2026 is available on the company website.
• Recording format: audio/video.
• Purpose: inform investors about availability of the earnings call recording.

Meeting Details

• Capital Markets Day 2026 for institutional investors and financial analysts on 4 September 2026.

Participants

• Key participant: Company Secretary & Compliance Officer.

Purpose

• Purpose: present updates to institutional investors and financial analysts during the Capital Markets Day.

Additional Notes

• Presentations will be submitted to stock exchanges and hosted on the company's website.

Business Overview

• Core consumer FMCG company with segments: Home Care, Beauty & Wellbeing, Personal Care, Foods.
• Strategic initiatives include portfolio transformation, market development, channel expansion, and AI-enabled distribution.

Key Operational Highlights

• Turnover ₹17,184 crore; USG 10% in Q1 JQ’26.
• EBITDA ₹3,947 crore; margin 23.0%.
• PAT before exceptional items rose 9% to ₹2,731 crore.
• PAT ₹2,680 crore, down 2% due to one-off tax credit in JQ’25.
• Home Care USG 14%; UVG high-single-digit.
• Beauty & Wellbeing USG 12%; UVG high-single-digit.
• Boost crossing ₹1,000 crore annual turnover milestone.
• Liquid I.V. sugar-free variant launched.
• Vaseline Gluta Hya Smoothening Body Lotion launched.
• Lux refreshed Bodywash proposition launched.
• Bru Southern Trails Coffee relaunch; Red Label Instant Tea and Kissan chutney variants extended.
• Vim Liquids continued to scale; double-digit growth.

Financial Performance

• Revenue growth 10%; EBITDA growth 8%; EBITDA margin 23.0%.
• Home Care revenue ₹6,554 crore; margin 17%.
• Beauty & Wellbeing revenue ₹4,083 crore; margin 28%.
• Personal Care revenue ₹2,624 crore; margin 20%.
• Foods revenue ₹3,480 crore; margin 20%.
• USG: Home Care 14%; Beauty & Wellbeing 12%; Personal Care 4%; Foods 7%.
• UVG: Home Care high-single-digit; Beauty & Wellbeing high-single-digit; Personal Care low-single-digit decline; Foods mid-single-digit.

Capital Structure & Liquidity

• No material debt/equity changes disclosed.
• Balance sheet and cash flows described as strong.

Strategic Priorities & Outlook

• FY27 expected to be better than FY26 due to portfolio and channel transformation.
• Volume-led growth anchored by portfolio, pricing, and channel investments.
• AI-enabled DC launched; AI across value chain.
• 8 Lighthouse designations across 6 sites.
• WEF Lighthouse factories; capital markets day scheduled 4 Sep 2026.
• Strengthening India as fragrance innovation hub; Unilever Fragrance House; 6x faster formulation development.
• R&D agility and adaptive manufacturing; Liquids Lab of the Future.

Risks & Mitigation

• Commodity volatility persists; inflationary pressures expected in near term.
• Monsoon and geopolitical developments could impact demand and supply.

Financial results approved

• Board approved unaudited standalone and consolidated results for the quarter ended 30 June 2026.
• Limited Review Reports from auditors Walker Chandiok & Co LLP enclosed with results.
• Results to be published in newspapers as per Listing Regulations; press release enclosed.
• Investor presentation on the unaudited results enclosed.

Audit and reporting

• Audit Committee reviewed the results on 27 July 2026; Board approved on 28 July 2026.
• Independent auditors issued unmodified review reports for standalone and consolidated results.

Key financial highlights

• Consolidated turnover ₹17,184 crores; EBITDA ₹3,947 crores; PAT before exceptional items ₹2,731 crores.
• Consolidated PAT after exceptional items ₹2,680 crores, down 2% due to prior-year tax credit.
• Standalone turnover ₹16,514 crores; EBITDA ₹3,768 crores; PAT before exceptional items ₹3,623 crores.
• Standalone PAT ₹2,631 crores; down 3% due to prior-year tax credit.
• Consolidated EBITDA margin 23.0%.

Dematerialisation processing status

• Processed dematerialisation requests within 15 days of receipt from Depository Participants.
• Dematerialised shares listed on the stock exchanges where the earlier issued shares were listed.
• Mutilated and cancelled the share certificates forwarded by Depository Participants.
• Substituted the depository's name as registered owner in the records.

Meeting Details

• Board meeting scheduled for Tuesday, 28 July 2026; time and venue not disclosed.

Key Agenda Items

• Consider unaudited standalone and consolidated results for quarter ended 30 June 2026, with Limited Review Report.

Other Notes

• Investors call and post-meeting presentation to analysts on 28 July 2026.
• Results to be intimated to exchanges and announced in a press release.